Background Primary liver cancer has high mortality and morbidity worldwide. However, the
characteristic of gut microbiota profile and its correlation with inflammation status in liver …

Objective To characterise gut microbiome in patients with hepatocellular carcinoma (HCC)
and evaluate the potential of microbiome as non-invasive biomarkers for HCC. Design We …

Hepatocellular carcinoma (HCC) is the second-most-common cause of cancer death. In
recent years, studies have suggested that intestinal microbiota dysregulation is closely …

Background The gut-liver axis plays a pivotal role in the pathogenesis of hepatocellular
carcinoma (HCC). However, the correlations between the gut microbiome and the liver …

Background Hepatocellular carcinoma (HCC) is the sixth most common cancer and the
fourth leading cause of cancer‐related death in the world. A number of challenges remain …

Oral, gut, and tumor microbiota have been implicated as important regulators in the
carcinogenesis and progression of gastrointestinal malignancies. However, few studies …

Background Hepatocellular carcinoma (HCC) is the third leading cause of cancer mortality
worldwide. Increasing evidence indicates a close relationship between HCC and the human …

Background Gut microbiota (GM) of patients with liver cancer is disordered, and syet no
study reported the GM distribution of liver cirrhosis‐induced HCC (LC‐HCC) and nonliver …

Hepatocellular carcinoma (HCC) is a malignant tumor with high incidence in China, which is
mainly related to chronic hepatitis B (CHB) and liver cirrhosis (LC) caused by hepatitis B …

Cholangiocarcinoma (CCA) is a malignant hepatic tumor with a poor prognosis, which
needs early diagnosis urgently. The gut microbiota has been shown to play a crucial role in …